Vertex Pharmaceuticals Inc
VRTX
$459.62+2.59 (+0.57%)
Jul 5, 2025, 4:00 PM
Financials
| 52Week High | 519.88 | 52Week Low | 377.85 |
| Beta | 0.44 | Current Ratio Annual | 2.69 |
| Current Ratio Quarterly | 2.65 | Gross Margin TTM | 86.03 |
| Market Cap | 118.03B | Net Profit Margin TTM | -8.91 |
| Operating Margin TTM | -6.69 | Price To Book | 7.15 |
| Price To Free Cash Flow TTM | 45.88 | Price To Sales TTM | 10.63 |
| Quick Ratio Annual | 2.23 | Quick Ratio Quarterly | 2.13 |
| Return On Assets TTM | -4.51 | Return On Equity TTM | -6.25 |
| Return On Investment TTM | -6.18 | Revenue Growth3Y | 13.31 |
| Revenue Growth5Y | 21.50 | Revenue Growth Quarterly Yoy | 2.96 |
| Revenue Growth TTMYoy | 8.98 | Revenue Per Share TTM | 42.77 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1522 | 181 | 169 | 595 | 547 | 175 | 240.64M | $109.35B |
| Jun 30, 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $0 |
| Change | 1.52K(100%) | 181(100%) | 169(100%) | 595(100%) | 547(100%) | 175(100%) | 240.64M(100%) | $109.35B(100%) |